// STATE LEGISLATION TRACKER

Illinois HB 3670: PHARMACY ACCOUNT & ACCESS ACT

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: In committee

State: Illinois
Bill: HB 3670
Session: 104th
Filed: 2025-02-07
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Illinois HB3670 would require large pharmacy operators to give 180 days' public notice before closing a pharmacy and explain the reason for the closure. It is mainly about preserving retail pharmacy access, not peptide prescribing, peptide compounding, telehealth, controlled substances, or FDA 503A/503B rules.

Key Points

No direct change to peptide prescribing or off-label use
No apparent change to 503A or 503B compounding rules
Could help patients plan around local pharmacy closures
Applies to larger pharmacy operators, not small clinics by default
No telehealth, PMP, or controlled-substance rule appears central

What to Watch For

✓

Opportunity Advance closure notice could reduce surprise gaps in access to prescriptions and supplies.

Note The bill appears focused on retail pharmacy access, not peptide-specific policy.

Concern Compliance costs for large pharmacy operators could indirectly affect service decisions.

Where the Bill Stands

The bill was re-referred to the House Rules Committee on March 21, 2025, so it has not passed a chamber.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws